StockDuty ← Dashboard Jul 30, 2026 03:02 PM ET
CatalystFDA/Bio

PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA

Strategic review phase 2 and extending nearest debt maturity to 2029 reduce refinancing risk.

Strategic review phase 2 and extending nearest debt maturity to 2029 reduce refinancing risk.
Sources